News | November 02, 2006

New Cooling Method Debuts for Cardiac Emergencies

A new cooling pad enters the healthcare market, joining a growing number of cooling systems used to induce hypothermia in some emergency cardiac arrest scenarios — the new treatment attempts to halt potential brain damage in cardiac patients. Life Recovery Systems HD, Alexandria, LA, will introduce its ThermoSuit at the American Heart Association’s annual scientific sessions in Chicago Nov. 12-15.

The technique is backed by several studies concluding that cooling patients can spare them some of the serious and permanent disabilities that often follow cardiac arrest — reducing body temperature to prevent brain damage was also endorsed a year ago by the American Heart Association.

The Life Recovery device is comprised of an air mattress that rises along the edges and has a clear plastic cover, a Morris County, NJ newspaper preorted. Cold water is pumped through the mattress, seeping through a membrane lining the inside and the cover to coat a patient's body and bring down the temperature.

Similar to the ice water immersion technique that hospitals have used for years, a company spokesman says it is easier to use, more precise and will not leave puddles on an emergency room floor. Patients are taken out of the ThermoSuit after 30 to 40 minutes and kept cooled with fans and additional applications of cold water if necessary.

The FDA approved the ThermoSuit based on showings that it worked as well as other devices on the market but without specifying a specific use.

In cardiac arrest cases, where an hour without treatment is usually a death sentence, Life Recovery claims a speed advantage.

For more information, visit

Related Content

therapeutic hypothermia, children, cardiac arrest, treatment, temperature
Feature | May 04, 2015
A large-scale, multicenter study has shown that therapeutic hypothermia does not improve survival rates or reduce brain...
News | December 11, 2014
Researchers at Okayama University in collaboration with several medical centers in Japan have demonstrated the safety...
Feature | September 19, 2014
September 19, 2014 — According to a new study, peritoneal hypothermia is feasible for patients who have suffered ST-...
Technology | July 10, 2014
July 10, 2014 — Life Recovery Systems announced the U.S. Food and Drug Administration (FDA) has approved two...
therapeutic hypothermia, Philips InnerCool

The Philips InnerCool RTx system was used in the CHILL-MI study for use in STEMI patients.

Feature | February 03, 2014 | Dave Fornell
Use of therapeutic hypothermia is used to prevent neurological damage in patients who suffer sudden cardiac arrest (SCA...
BeneChill RhinoChill Therapeutic Hypothermia Cath Lab Intranasal Cooling System
News | January 22, 2014
BeneChill Inc. received the 2014 Frost & Sullivan Award for Technology Innovation Leadership for its RhinoChill...
rhinochill, RhinoChill, benechill, BeneChill

RhinoChill IntraNasal Cooling System

News | December 03, 2013
With the benefits of conventional strategies for therapeutic hypothermia following cardiac arrest being called in to ...
therapeutic hypothermia temperature management cath lab clinical trial study
Feature | November 01, 2013
clinical trial shows that rapidly cooling...
News | October 01, 2013
The Cardiovascular Research Foundation (CRF) announced the late breaking trials and first report investigations that...
News | August 06, 2013
Vanderbilt Heart and Vascular Institute is participating in the VELOCITY study, a randomized controlled clinical study...
Overlay Init